These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members. Jing S, Naliboff A, Kaufman MB, Choy M. J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805 [Abstract] [Full Text] [Related]
24. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC, Krein SL, Stroupe KT, Sharp ND, Liu CF. Am J Manag Care; 2010 Jan 01; 16(1):e20-34. PubMed ID: 20059288 [Abstract] [Full Text] [Related]
25. Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors. Lauffenburger JC, Franklin JM, Krumme AA, Shrank WH, Matlin OS, Spettell CM, Brill G, Choudhry NK. J Manag Care Spec Pharm; 2018 May 01; 24(5):469-477. PubMed ID: 29694288 [Abstract] [Full Text] [Related]
26. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics. Lester CA, Mott DA, Chui MA. J Manag Care Spec Pharm; 2016 Jul 01; 22(7):801-7. PubMed ID: 27348281 [Abstract] [Full Text] [Related]
31. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics. Bernard K, Cowles B, McCall K, Henningsen RM, O'Toole M, Tu C. J Am Pharm Assoc (2003); 2019 Jul 01; 59(3):343-348. PubMed ID: 30940515 [Abstract] [Full Text] [Related]
34. Effect of the ExactCare medication care management model on adherence, health care utilization, and costs. Shetty KD, Chen AY, Rose AJ, Liu HH. J Manag Care Spec Pharm; 2021 May 01; 27(5):574-585. PubMed ID: 33560167 [Abstract] [Full Text] [Related]
36. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors. Rascati KL, Worley K, Meah Y, Everhart D. J Manag Care Spec Pharm; 2017 Mar 01; 23(3):299-306. PubMed ID: 28230454 [Abstract] [Full Text] [Related]
37. Longitudinal medication adherence group-based trajectories of aging adults in the US: A retrospective analysis using monthly proportion of days covered calculations. Pontinha VM, Patterson JA, Dixon DL, Carroll NV, Mays D, Barnes A, Farris KB, Holdford DA. Res Social Adm Pharm; 2024 Mar 01; 20(3):363-371. PubMed ID: 38176956 [Abstract] [Full Text] [Related]
38. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA. Ann Intern Med; 2012 Jun 05; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815 [Abstract] [Full Text] [Related]
39. A Payer Perspective of the Costs of Urinary Tract and Skin and Soft Tissue Infections in Adults with Diabetes and the Relationship to Oral Antidiabetic Medication Nonadherence. Davis-Ajami ML, Pakyz A, Wu J, Baernholdt M. J Manag Care Spec Pharm; 2019 Dec 05; 25(12):1409-1419. PubMed ID: 31436479 [Abstract] [Full Text] [Related]
40. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes. Bibeau WS, Fu H, Taylor AD, Kwan AY. J Manag Care Spec Pharm; 2016 Nov 05; 22(11):1338-1347. PubMed ID: 27783549 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]